Recursion Pharmaceuticals (NASDAQ:RXRX) used its latest earnings call to emphasize what management described as an inflection ...
Recursion Pharmaceuticals RXRX, a TechBio company that decodes biology and chemistry to industrialize drug discovery, is expected to report fourth-quarter 2025 results soon. The Zacks Consensus ...
VANCOUVER, Wash. and NEW YORK, Feb. 17, 2026 (GLOBE NEWSWIRE) -- Absci Corporation (Nasdaq: ABSI), a clinical-stage biopharmaceutical company advancing breakthrough therapeutics with generative AI, ...
Veradermics, Incorporated (MANE) has filed for a proposed $200 million IPO of its common stock, per an amended SEC IPO prospectus. The company is a clinical-stage biotech firm developing a new ...
03 February 2026, Bavaria, Munich: The Microsoft logo and lettering can be seen on the Microsoft Deutschland GmbH headquarters building in Parkstadt Schwabing in Munich (Bavaria). Microsoft ...
Multi-agent orchestration makes workflow more inspectable, with clear handoffs and a QA backstop. Breaking the work into discrete steps makes the output easier to audit and fix. A timestamped handoff ...
Visual Studio Code 1.109 introduces structured, multi-agent workflows that move AI assistance beyond single-chat interactions. Parallel subagents enable concurrent task execution without consuming the ...
Absci Corp. is the drug and target discovery company harnessing deep learning AI and synthetic biology to expand the therapeutic potential of proteins. It partners with pharma and biotech innovators ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results